ˈɛθaɪlstɹˌɛnɑːl, ˈɔːlsoʊ nˈoʊn æz ˈɛθɪlˌoʊstɹənˌɑːl ɔːɹ ˈɛθəlnˌændɹɑːl ænd sˈoʊld ˌʌndɚ ðə bɹˈænd nˈeɪmz mˈæksɪbˌɑːlɪn ænd ˈoːɹɐbˌɑːlɪn ɐmˌʌŋ ˈʌðɚz, ɪz ɐn ˈændɹədʒən ænd ˌænɐbˈɑːlɪk stˈɛɹɔɪd ˌeɪˌeɪˈɛs mˌɛdɪkˈeɪʃən wˌɪtʃ hˈæzbiːn jˈuːzd ɪnðə pˈæst fɚɹə vɚɹˈaɪəɾi ʌv ˌɪndɪkˈeɪʃənz sˈʌtʃ ɐz tə pɹəmˈoʊt wˈeɪt ɡˈeɪn ænd tə tɹˈiːt ɐnˈiːmiə ænd ˌɑːstɪˌɑːpoːɹˈoʊsɪs bˌʌt hˈæzbiːn dɪskəntˈɪnjuːd fɔːɹ jˈuːs ɪn hjˈuːmənz.
Ethylestrenol, also known as ethyloestrenol or ethylnandrol and sold under the brand names Maxibolin and Orabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used in the past for a variety of indications such as to promote weight gain and to treat anemia and osteoporosis but has been discontinued for use in humans.